|
Forecast
Period
|
2025-2029
|
|
Market
Size (2023)
|
USD
55.34 Million
|
|
Market
Size (2029)
|
USD
73.69 Million
|
|
CAGR
(2024-2029)
|
5.06%
|
|
Fastest
Growing Segment
|
Angioplasty
Stents
|
|
Largest
Market
|
Dubai
|
Market Overview
UAE
Interventional Cardiology Devices Market was valued at USD
55.34 Million in 2023 and is anticipated to project impressive growth in
the forecast period with a CAGR of 5.06% through 2029. The UAE interventional
cardiology devices market represents a vital segment within the broader
healthcare sector, driven by several key factors. And the rising facilities
leads to the growth of cardiovascular devices market. For instance, In
October 2022, FibriCheck collaborated with Pfizer and Altibbi to initiate an awareness
campaign aimed at identifying atrial fibrillation (AF) in the UAE. The campaign
focuses on raising awareness about AF detection using innovative digital health
solutions. FibriCheck's technology allows users to monitor their heart rhythm
remotely through smartphone apps, enabling early detection of irregularities.
Partnering with Pfizer and Altibbi enhances outreach efforts and underscores
the importance of proactive AF screening in improving cardiovascular health
across the Emirates. As a dynamic and rapidly evolving market, it
encompasses a variety of devices crucial for diagnosing and treating
cardiovascular diseases (CVDs), which remain a leading cause of mortality in
the region. Angioplasty stents, including bare-metal and drug-eluting variants,
are pivotal in restoring blood flow to blocked arteries, thereby reducing the
risk of heart attacks and improving patient outcomes. Their dominance is
underscored by continuous advancements in stent design, materials, and
coatings, aimed at enhancing efficacy and reducing complications like
restenosis.
Also,
Catheters play a critical role in guiding interventional procedures such as
angioplasty and stent placement, ensuring precision and safety during
operations. Structural heart devices, including transcatheter heart valves and
closure devices, cater to a growing demand for minimally invasive treatments of
congenital heart defects and valve disorders. Plaque modification devices and
hemodynamic flow alteration devices further complement these advancements,
offering innovative solutions to manage complex cardiovascular conditions.
The
market's growth is bolstered by factors such as rising incidences of
lifestyle-related diseases, increasing healthcare expenditure, and government
initiatives to expand healthcare infrastructure. Moreover, the UAE's position
as a hub for medical tourism further drives demand for cutting-edge
interventional cardiology procedures and devices. With ongoing technological
innovations and strategic investments, the UAE interventional cardiology
devices market is poised for continued expansion, contributing significantly to
improving cardiovascular care and patient outcomes across the Emirates.
Key Market Drivers
Increasing Prevalence of
Cardiovascular Diseases
The
increasing prevalence of cardiovascular diseases (CVDs) in the UAE underscores
the critical importance of the interventional cardiology devices market.
Lifestyle factors such as sedentary lifestyles, high-calorie diets, and stress
contribute significantly to the rising incidence of CVDs, including coronary
artery disease, hypertension, and heart failure among the UAE population. These
conditions not only affect older adults but are increasingly prevalent among
younger age groups due to changing dietary habits and reduced physical
activity. In response to this health challenge, the demand for advanced
interventional cardiology devices such as angioplasty stents, catheters, and
structural heart devices has grown substantially. These devices are essential
for diagnosing and treating various cardiovascular conditions, offering
minimally invasive solutions that reduce recovery times and improve patient
outcomes. The UAE's healthcare infrastructure has adapted to accommodate this
demand, with hospitals and specialized cardiac centers equipped with
state-of-the-art technology and skilled healthcare professionals capable of
performing complex interventional procedures. According to the research
article published in National Institute of Health, 2023, Cardiovascular
diseases (CVDs) rank among the primary causes of death worldwide and contribute
to 40% of mortality in the United Arab Emirates (UAE). The recent UAE National
Health Survey underscored CVDs as a major health concern, highlighting physical
inactivity, hypertension, obesity, and tobacco use as leading risk factors for
CVD-related fatalities. The UAE Health Vision 2021 prioritizes reducing CVD
risk factors and mortality rates, prompting substantial funding allocation
towards cardiovascular research initiatives. As the prevalence of CVDs continues to
rise, driven by demographic changes and lifestyle factors, the interventional
cardiology devices market in the UAE is poised for further expansion. Continued
innovation in device technology and increased access to specialized cardiac
care are essential to meet the evolving healthcare needs of the population and
mitigate the impact of cardiovascular diseases on public health. Also, according
to the research article published in National Institute of Health, 2024, in the
UAE, approximately 71% of adults and over 30% of children are affected by
overweight or obesity. Statistics also indicate that the country has the
world's second highest prevalence of diabetes, impacting 18.7% of the
population, and a notable smoking rate with 9.1% of residents being smokers.
These figures underscore the urgency to allocate greater resources towards
researching lifestyle factors that contribute to cardiovascular disease (CVD).
Enhancing public awareness and implementing effective interventions are crucial
steps to mitigate the impact of these risk factors on the population's
cardiovascular health in the UAE.
Technological Advancements
Technological
advancements play a pivotal role in shaping the UAE's interventional cardiology
devices market, driving innovation and improving patient outcomes. One of the
most significant advancements is the development of drug-eluting stents (DES),
which release medication to prevent restenosis (re-narrowing of arteries)
following angioplasty. DES technology has significantly reduced the need for
repeat procedures and improved long-term efficacy compared to bare-metal
stents. Advancements in imaging technologies such as intravascular ultrasound
(IVUS) and optical coherence tomography (OCT) enhance the precision of
procedures by providing detailed images of blood vessels, aiding in stent
placement and optimizing treatment outcomes. These imaging modalities help
cardiologists assess plaque burden, vessel dimensions, and stent apposition
accurately.
Robotic-assisted
interventions are gaining traction, offering enhanced dexterity and control
during procedures, thereby reducing procedural risks and improving patient
safety. Miniaturization of devices, including microcatheters and guidewires,
enables access to complex anatomies and facilitates navigational challenges in
intricate vascular pathways.
The
technological advancements in interventional cardiology devices not only
enhance procedural efficiency but also expand treatment options for complex
cardiovascular conditions. As these innovations continue to evolve, they are
expected to drive further growth and differentiation within the UAE's
interventional cardiology devices market, supporting its position as a leader
in cardiovascular care in the region.
Growing Healthcare
Infrastructure
The
UAE's growing healthcare infrastructure is a significant catalyst for the
expansion of the interventional cardiology devices market. The country has made
substantial investments in building modern hospitals, specialized cardiac
centers, and advanced catheterization labs equipped with state-of-the-art
imaging and interventional technologies. This infrastructure expansion not only
enhances the capacity to deliver high-quality cardiovascular care but also
supports the adoption of cutting-edge interventional cardiology devices.
The
presence of world-class healthcare facilities in cities like Dubai and Abu
Dhabi attracts a diverse patient population, including local residents and
international medical tourists seeking specialized cardiac treatments. These
facilities offer comprehensive cardiac services, ranging from diagnostic
procedures to complex interventional therapies, ensuring timely and effective
management of cardiovascular conditions. For instance, In August 2022,
Thumbay University Hospital, a leading healthcare provider in the UAE, unveiled
a cutting-edge facility dedicated to addressing chest pain concerns among
patients facing life-threatening events. The center offers comprehensive
non-invasive cardiac diagnostic services encompassing coronary catheterization,
EKG-ECG monitoring, stent follow-up, 24-hour Holter monitoring, dobutamine
stress echocardiography, Ex-ECG, congestive heart failure diagnosis and
management, complete executive physicals, exercise stress tests, cholesterol
treatment, as well as carotid and peripheral doppler assessments.
UAE
government's initiatives to promote healthcare excellence and innovation
through regulatory support and investment incentives further bolster the growth
of the interventional cardiology devices market. The continuous expansion and
upgrading of healthcare infrastructure across the Emirates contribute to
improved accessibility, affordability, and quality of cardiovascular care,
reinforcing the UAE's position as a leading hub for advanced medical treatments
in the region.
Increasing Healthcare
Expenditure
The
increasing healthcare expenditure in the UAE has a profound impact on the
interventional cardiology devices market, driving growth and innovation in
cardiovascular care. As the population grows and ages, coupled with rising
incidences of chronic diseases like cardiovascular conditions, there is a
heightened demand for advanced medical treatments and technologies. This
includes interventional cardiology devices such as angioplasty stents,
catheters, and imaging systems, which are essential for diagnosing and treating
complex cardiovascular diseases. The UAE's rising healthcare expenditure
reflects investments in expanding healthcare infrastructure, upgrading medical
technologies, and enhancing healthcare services to meet international
standards. These investments not only improve patient outcomes but also support
the adoption of state-of-the-art interventional cardiology devices across the
country's healthcare facilities. The increased healthcare expenditure
facilitates access to specialized cardiac care, including interventional
procedures, for both residents and medical tourists. This growth is further
propelled by the government's commitment to healthcare excellence through
regulatory frameworks that promote innovation and ensure patient safety. Overall,
rising healthcare expenditure in the UAE underscores a commitment to advancing
cardiovascular care, positioning the market for sustained expansion and
technological advancement in interventional cardiology devices.
Download Free Sample Report
Key Market Challenges
Regulatory Environment
The
regulatory environment in the UAE's interventional cardiology devices market
plays a crucial role in shaping market dynamics and ensuring patient safety.
The Emirates Authority for Standardization and Metrology (ESMA) and the
Ministry of Health and Prevention (MOHAP) oversee the regulation and approval
of medical devices, including interventional cardiology devices, ensuring they
meet stringent quality and safety standards.
Challenges
in the regulatory environment include navigating complex approval processes for
new devices, which can involve rigorous testing, clinical trials, and
documentation requirements. Companies entering the market must comply with
local regulations and obtain necessary certifications, such as the Conformity
Assessment Certificate (CAC) and Registration Certificate, before
commercializing their products.
Harmonizing
UAE regulations with international standards is also important for facilitating
market access and promoting innovation. Alignment with recognized regulatory
frameworks like the CE Mark (European Conformity) or FDA (Food and Drug
Administration) approvals can streamline the approval process for multinational
manufacturers. Continuous updates and amendments to regulatory guidelines
ensure that interventional cardiology devices in the UAE adhere to evolving
technological advancements and global best practices. This regulatory oversight
aims to protect patient safety, maintain healthcare quality standards, and
foster a competitive marketplace for innovative medical technologies.
Cost Constraints
Cost
constraints present significant challenges within the UAE interventional
cardiology devices market, impacting both healthcare providers and patients.
The high costs associated with advanced interventional procedures and devices,
such as angioplasty stents and imaging technologies, can pose barriers to
accessibility and affordability. Healthcare facilities must contend with the
expense of acquiring and maintaining state-of-the-art equipment, as well as the
costs of training personnel to operate these technologies effectively. For
patients, out-of-pocket expenses for interventional cardiology procedures can
be substantial, particularly if they lack comprehensive insurance coverage.
This financial burden may deter individuals from seeking timely medical
interventions or opting for less invasive treatments, potentially compromising
their health outcomes. The pricing strategies of medical device manufacturers
and distributors influence overall healthcare expenditures. Negotiating
competitive pricing and cost-effective solutions becomes crucial for healthcare
providers striving to deliver quality care while managing budget constraints. Addressing
cost constraints requires collaborative efforts among stakeholders, including
government entities, healthcare providers, insurers, and manufacturers.
Initiatives to streamline procurement processes, negotiate favorable pricing
agreements, expand insurance coverage, and promote cost-effective technologies
are essential to enhance affordability and ensure equitable access to
interventional cardiology devices and procedures in the UAE.
Key Market Trends
Minimally Invasive Procedures
Minimally invasive procedures represent
a significant trend in the UAE's interventional cardiology devices market,
revolutionizing the treatment of cardiovascular diseases. These procedures
involve accessing the heart and blood vessels through small incisions or
punctures, rather than traditional open-heart surgery. Key advancements include
percutaneous coronary interventions (PCI), such as angioplasty and stent
placement, which are performed using catheters guided by imaging technologies
like fluoroscopy and intravascular ultrasound (IVUS). Minimally invasive
techniques offer several advantages over traditional surgery, including reduced
recovery times, shorter hospital stays, lower risk of complications, and
quicker return to normal activities for patients. This approach aligns with
patient preferences for less invasive treatments that minimize discomfort and
downtime. In the UAE, the adoption of minimally invasive procedures is
supported by the presence of advanced catheterization labs equipped with state-of-the-art
imaging and navigation systems. These facilities enable cardiologists to
perform complex interventions with high precision and safety.
As technological innovations continue to
enhance the capabilities of minimally invasive devices and techniques, their
popularity is expected to grow, driving market demand for specialized
interventional cardiology devices tailored to support these procedures
effectively.
Structural Heart Interventions
Structural heart interventions are a
significant and growing segment within the UAE's interventional cardiology
devices market, focusing on treating complex heart conditions without the need
for open-heart surgery. These interventions address structural abnormalities or
defects of the heart, such as valve disorders and congenital heart defects,
using minimally invasive techniques. Transcatheter procedures like
transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve
repair (TMVR) are among the most prominent structural heart interventions. TAVR
involves replacing a diseased aortic valve with a prosthetic valve delivered
via a catheter, typically through the femoral artery, minimizing the need for
sternotomy and reducing recovery times. TMVR, on the other hand, repairs the
mitral valve using specialized devices delivered via catheters, addressing
issues like mitral regurgitation. These procedures are gaining traction
in the UAE due to their effectiveness in treating high-risk patients who may
not be suitable candidates for traditional surgery. The country's advanced
healthcare infrastructure, including specialized cardiac centers equipped with
cutting-edge imaging technologies and skilled interventional cardiologists,
supports the growth of structural heart interventions. As the population ages
and cardiovascular diseases become more prevalent, the demand for these
minimally invasive treatments is expected to rise, driving innovation and
investment in interventional cardiology devices tailored for structural heart
interventions in the UAE.
Segmental Insights
Product Type Insights
Based on the Product Type, Angioplasty
Stents have asserted dominance in the UAE Interventional Cardiology Devices
Market. angioplasty stents are dominant in the field of cardiovascular
interventions. Stents are crucial as they provide structural support to
arteries following angioplasty, which involves opening narrowed or blocked
blood vessels to improve blood flow. Their dominance stems from their essential
role in treating coronary artery disease, a prevalent condition in the UAE and
globally. Stents help maintain vessel patency and reduce the risk of
re-narrowing (restenosis) post-procedure, thereby improving long-term outcomes
for patients. Advancements in stent technology, including drug-eluting stents
that release medication to prevent restenosis, have significantly enhanced
their efficacy and safety. This has solidified their position as a preferred
choice in cardiovascular interventions. The increasing adoption of minimally
invasive procedures and the growing prevalence of lifestyle-related diseases contribute
to the sustained demand for angioplasty stents in the UAE and worldwide, making
them a dominant category within the cardiovascular device market.
Download Free Sample Report
Regional Insights
Dubai stands out as dominant in the
UAE's interventional cardiology devices market for several compelling reasons.
The city boasts a robust healthcare infrastructure that includes world-class
hospitals, specialized cardiac centers, and advanced catheterization labs
equipped with cutting-edge interventional technologies. These facilities
attract top-tier medical professionals and specialists, making Dubai a
preferred destination for complex cardiac procedures, including interventional
cardiology treatments.
Dubai's strategic geographical location
and excellent connectivity serve as a gateway for medical tourism from
neighboring countries and globally. The city's reputation for quality
healthcare services and state-of-the-art medical facilities draws a diverse
patient population seeking advanced treatments, including minimally invasive
interventional cardiology procedures. Dubai's proactive healthcare policies and
regulatory frameworks support innovation and investment in medical
technologies. The government's initiatives to promote Dubai as a hub for
medical excellence and innovation encourage the adoption of advanced
interventional cardiology devices and procedures. This environment fosters
competition among healthcare providers, driving continuous improvements in
patient care and outcomes. The presence of international healthcare
partnerships and collaborations enhances Dubai's capabilities in offering the
latest interventional cardiology technologies and techniques. These
collaborations facilitate knowledge exchange, training programs, and access to
innovative medical devices, further solidifying Dubai's leadership in the
interventional cardiology devices market within the UAE.
Dubai's combination of advanced
healthcare infrastructure, strategic location, supportive regulatory
environment, and international collaborations positions it as a dominant force
in the UAE's interventional cardiology devices market, catering not only to
local residents but also to a global clientele seeking state-of-the-art cardiac
care.
Recent Developments
- In October
24, 2023, Medinol disclosed that the EluNir-Perl drug-eluting stent (DES)
received approval from the United States FDA for treating coronary artery
disease. This next-generation stent expands on the proven efficacy and clinical
data of the EluNir DES system, initially approved in 2017 for patients
suffering from coronary artery narrowing or blockages. The new EluNir-Perl DES
incorporates enhanced features aimed at further improving patient outcomes,
marking a significant advancement in interventional cardiology treatments for
managing cardiovascular conditions different regions.
Key Market Players
- Medtronic
Meta FZ-LLC
- Boston Scientific Corporation
- Abbott Laboratories, S.A.
- Biotronik UAE
- Edwards LifeSciences UAE
- B. Braun Medical Gulf FZ-LLC
- Terumo Middle East FZE
- Cook Medical UAE
- Vasmed UAE
- Life Mate Medical Equipment Trading
LLC
|
By
Product Type
|
By
End User
|
By
Region
|
- Angioplasty
Balloons
- Angioplasty
Stents
- Structural
Heart Devices
- Catheters
- Plaque
Modification Devices
- Hemodynamic
Flow Alteration Devices
- Others
|
- Hospitals
& Clinics
- Ambulatory
Surgery Centers
- Others
|
- Abu
Dhabi
- Dubai
- Sharjah
- Rest
of UAE
|
Report Scope:
In this report, the UAE Interventional Cardiology Devices Market has
been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- UAE Interventional Cardiology
Devices Market, By Product Type:
o
Angioplasty Balloons
o
Angioplasty Stents
o
Structural Heart Devices
o
Catheters
o
Plaque Modification Devices
o
Hemodynamic Flow Alteration Devices
o
Others
- UAE Interventional Cardiology
Devices Market, By End User:
o
Hospitals & Clinics
o
Ambulatory Surgery Centers
o
Others
- UAE Interventional Cardiology
Devices Market, By Region:
o
Abu Dhabi
o
Dubai
o
Sharjah
o
Rest of UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies presents in the UAE Interventional Cardiology
Devices Market.
Available Customizations:
UAE
Interventional Cardiology Devices Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
UAE Interventional Cardiology Devices Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]